Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
by Ruben Mesa
MPD-RC 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
by John Mascarenhas
MAJIC trial results: ruxolitinib compared to best available therapy for essential thrombocythemia
by Claire Harrison
What is the unmet medical need of patients with PV and ET?
by Haifa Kathrin Al-Ali
What's new in myeloproliferative neoplasms?
by Jean-Jacques Kiladjian